title: Hybrid imaging for pancreatic malignancy: clinical applications, merits, limitations, and pitfalls.
abstract: The role of PET/CT in pancreatic malignancy is evolving with new scientific evidence emerging continuously. PET/CT applications in imaging the pancreas and its organ-specific merits, limitations, and potential pitfalls are still evolving. This article provides an overview of the state-of-the-art applications of PET/CT imaging in evaluating pancreatic malignancy, comparing with conventional imaging modalities, such as contrast-enhanced CT and MRI. Current PET/MRI is also reviewed, along with brief discussion on cost-benefit analysis.
authors.affiliation: From the Department of Radiology and Nuclear Medicine, University of California Davis Medical Center, Sacramento, CA.
authors.forename: Priyanka
authors.initials: P
authors.lastname: Jha
authors.forename: Bijan
authors.initials: B
authors.lastname: Bijan
authors.forename: Giselle
authors.initials: G
authors.lastname: Melendres
authors.forename: David K
authors.initials: DK
authors.lastname: Shelton
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects / Q000379:methods*; D064847:Multimodal Imaging / Q000009:adverse effects / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000009:adverse effects / Q000379:methods*; D014057:Tomography, X-Ray Computed / Q000009:adverse effects / Q000379:methods*